drugset / Trial / NCT07639177
Faecal Microbiota Transplantation in Patients With Refractory Rheumatoid Arthritis
Phase 2
Not yet recruiting
40 enrolled
Peking Union Medical College Hospital
Qingdao Haier Biotech Co., LTD · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
In this 24-week, single center, randomized, double-blind, placebo-controlled study, the efficacy and safety of lyophilised oral fecal microbiota transplantation in patients with active refractory rheumatoid arthritis will be evaluated.
Timeline
- Start
- 2026-06-15
- Primary completion
- 2028-06-01
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Faecal microbiota | Other / unclassified | — | Oral |